drugset / Trial / NCT06911203
A Study of BGM0504 in Participants With Obesity
RandomizedParallel-groupOpen-labelTreatment
Summary
To evaluate the efficacy and safety of BGM0504 compared with Tirzepatide in adult participants who have obesity without diabetes after 26 weeks of treatment.
Timeline
- Start
- 2025-04-03
- Primary completion
- 2026-01-11
- Completion
- 2026-01-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BGM0504 | Unknown | — | Subcutaneous |
| Comparator | Tirzepatide | Peptide | — | Subcutaneous |